GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 738-746

  Neill, Graham W ^a   Harrison, Wesley J ^a   Ikram, Mohammed S ^a   Williams, Tomos D L ^a   Bianchi, Lucia S ^a   Nadendla, Sandeep K ^a   Green, Judith L ^a,c   Ghali, Lucy ^a,d   Frischauf, Anna Maria ^b   O'Toole, Edel A ^a   Aberger, Fritz ^b   Philpott, Michael P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SALZBURG   (Austria)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ARTICLE; BASAL CELL CARCINOMA; CELL ADHESION; CELL MIGRATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

CARCINOMA, BASAL CELL; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; EPIDERMIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, REPORTER; HUMANS; KERATINOCYTES; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 41849124899     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn037     Document Type: Article

References (72)

1. Miller,S.J. (1995) Etiology and pathogenesis of basal cell carcinoma. Clin. Dermatol., 13, 527-536.
2. Gailani,M.R. et al. (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat. Genet. 14, 78-81.
3. Hahn,H. et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 85, 841-851.
4. Johnson,R.L. et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science, 272, 1668-1671.
5. Kasper,M. et al. (2006) GLI transcription factors: Mediators of oncogenic Hedgehog signalling. Eur. J. Cancer, 41, 437-445.
6. Pasca di Magliano,M. et al. (2003) Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer, 3, 903-911.
7. Dahmane,N. et al. (1997) Activation of the transcription factor Glil and the Sorfic hedgehog signalling pathway in skin tumours. Nature, 389, 876-881.
8. Grachtchouk,M. et al. (2000) Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet., 24, 216-217.
9. Nilsson,M. et al. (2000) Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl Acad. Sci. USA, 97, 3438-3443.
10. Beachy,P.A. et al. (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature, 432, 324-331.
11. Hutchin,M.E. et al. (2005) Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev., 19, 214-223.
12. Oro,A.E. et al. (2003) Hair cycle regulation of Hedgehog signal reception. Dev. Biol., 255, 238-248.
13. Xie,J. et al. (2001) A role of PDGRalpha in basal cell carcinoma proliferation. Proc. Natl Acad. Sci. USA, 98, 9255-9259.
14. Mullor,J.L. et al. (2001) Wnt signals are targets and mediators of Gli function. Curr. Biol., 11, 769-773.
15. Teh,M.T. et al. (2002) FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res., 62, 4773-4780.
16. Yoon,J.W. et al. (2002) Gene expression profiling leads to identification of GL11-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem., 277, 5548-5555.
17. Louro,I.D. et al. (2002) Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res., 62, 5867-5873.
18. Regl,G. et al. (2004) The zinc-finger transcription factor GLI2 antagonizes contact inhibition, and differentiation of human epidermal cells. Oncogene, 23, 1263-1274.
19. Li,X. et al. (2007) Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene, 26, 4489-4498.
20. Ingham,P.W. et al. (2001) Hedgehog signaling in animal development: Paradigms and principles. Genes Dev., 15, 3059-3087.
21. Callahan,C.A. et al. (2004) MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev., 18, 2724-2729.
22. Huangfu,D. et al. (2003) Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature, 426, 83-87.
23. Liu,A. et al. (2005) Mouse intraflagellar transport proteins regulate both the activator and repressor functions of Gli transcription factors. Development, 132, 3103-3111.
24. Barnes,E.A. et al. (2005) Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene, 24 902-915.
25. Goyette,P. et al. (2000) Regulation of gli activity by all-trans retinoic acid in mouse keratinocytes. Cancer Res., 60, 5386-5389.
26. Mao,J. et al. (2002) Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem., 277, 35156-35161.
27. Neill,G.W. et al. (2003) Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res., 63, 4692-4697.
28. Riobo,N.A. et al. (2006) Protein kinase C-delta and mitogen-activated protein/extracellular signal-reguIated kinase-1 control GLI activation in hedgehog signaling. Cancer Res., 66 839-845.
29. Riobo,N.A. et al. (2006) Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl Acad, Sci. USA, 103, 4505-4510.
30. Stecca,B. et al. (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc. Natl Acad. Sci. USA, 104, 5895-5900.
31. Kasper,M. et al. (2006) Selective modulation of Hedgehog/GLI target gene expression by epidermal growt factor signaling in human keratinocytes, Mol. Cell. Biol., 26, 6283-6298.
32. Regl,G. et al. (2002) Human GLI2 and GLI1 are part of a positive feedback mechanism in basal cell carcinoma. Oncogene, 21, 5529-5539.
33. Greulich,H. et al. (2005) Oncogenic transformation by inhibitor-sensitive and resistant EGFR mutants. PLoS Med., 2 e313.
34. Kogerman,P. et al. (1999) Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat. Cell Biol., 1, 312-319.
35. Sheng,T. et al. (2006) Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. J. Biol. Chem., 281, 9-12.
36. Zhang,J. et al. (2005) Actin at cell-cell junctions is composed of two dynamic and functional populations. J. Cell Sci., 118, 5549-5562.
37. Rajalingam,K. et al. (2005) Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 7, 837-843.
38. Waetzig,V. et al. (2005) MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling. Mol. Cell. Neurosci., 30, 67-78.
39. Xia,Y. et al. (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol., 14, 94-101.
40. Grose,R. (2001) Epithelial migration: Open your eyes to c-Jun. Curr. Biol., 13, R678-R680.
41. McCawley,L.J. et al. (1997) Overexpression of the epidermal growth factor receptor contributes to enhanced ligand-mediated motility in keratinocyte cell lines. Endocrinology, 138, 121-127.
42. Li,X. et al. (2006) Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 25, 609-621.
43. Thiery,J.P., (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
44. Huntzicker,E.G. et al. (2006) Dual degradation signals control Gli protein stability and tumor formation. Genes Dev., 20, 276-281.
45. Kent,D. et al. (2006) Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. Development, 133 2001-2010.
46. Zhang,Q. et al. (2006) A hedgehog-indwced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription-factor. Dev. Cell. 10, 719-729.
47. Jensen,U.B. et al. (1999) The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: A new view based on whole-mount labelling snd lineage analysis. Devolopment 126, 2409-2418.
48. Tani,H. et al. (2000), Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc. Natl Acad Sci. USA, 97, 10960-10965.
49. Zhou,J.X. et al. (2004) Enrichment and identification of human 'fetal' epidermal stem cells. Hum. Reprod. 19, 968-974.
50. Fortunel,N.O. et al. (2003) Long-term expansion of human functional epidermal precursor cells: Promotion of extensive amplification by low TGF-beta1 concentrations. J. Cell Sci., 116, 4043-4052.
51. Jensen,K.B. et al. (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc. Natl Acad. Sci. USA, 103, 11958-11963.
52. Palma,V. et al. (2005) Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development, 132, 335-344.
53. Palma,V. et al. (2004) Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development, 131, 337-345.
54. Bigelow,R.L. et al. (2005) Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCAT keratinocytes. J. Invest. Dermatol., 124, 457-465.
55. Wicha,M.S. et al. (2006) Cancer stem cells: So old idea - a paradigm shift. Cancer Res., 66, 1883-1890. discussion, 1895-1896.
56. Clement,V. et al. (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17, 165-172.
57. Liu,S. et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063-6071.
58. Nazmi,M.N. et al. (1990) Epidermal growth factor receptors in human epidermal tumours. Br J. Dermatol. 123, 153-161.
59. Krahn,G. et al. (2001) Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer. Eur. J. Cancer 37, 251-259.
60. O'Driscoll,L. et al. (2006) Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol. Cancer 5, 74.
61. Rittie,L. et al. (2007) Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am. J. Pathol. 170, 2089-2099.
62. Marmor,M.D. et al. (2004) Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23, 2057-2070.
63. Fogarty,G.B. et al. (2007) Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin. Br. J. Dermatol. 156, 92-98.
64. Courtois-Cox,S. et al. (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10 459-472.
65. Gil,J. et al. (2005) Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res. 65, 2179-2185.
66. Karhadkar,S.S. et al. (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 701-712.
67. Phillips,H.S. et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173.
68. Yarden,Y. (2001) The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37 (suppl. 4), S3-S8.
69. Berk,A.J. (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24, 7673-7685.
70. Pizarro,A. et al. (1994) E-cadherin expression in basal cell carcinoma. Br. J. Cancer 69, 157-162.
71. Pizarro,A. et al. (1995) Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours. Br. J. Cancer 72, 327-332.
72. Green,J. et al. (1998) Basal cell carcinoma development is associated with induction of the expression of the transcription factor Gli-1. Br. J. Dermatol. 139, 911-915.